RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF
申请人:The Johns Hopkins University
公开号:US20210094933A1
公开(公告)日:2021-04-01
The present disclosure provides macrocyclic compounds inspired by the immunophilin ligand family of natural products FK506 and rapamycin. The generation of a Rapafucin library of macrocyles that contain FK506 and rapamycin binding domains should have great potential as new leads for developing drugs to be used for treating diseases.
Rapafucin derivative compounds and methods of use thereof
申请人:The Johns Hopkins University
公开号:US11066416B2
公开(公告)日:2021-07-20
The present disclosure provides macrocyclic compounds inspired by the immunophilin ligand family of natural products FK506 and rapamycin. The generation of a Rapafucin library of macrocyles that contain FK506 and rapamycin binding domains should have great potential as new leads for developing drugs to be used for treating diseases.
[EN] RAPAFUCIN DERIVATIVE COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS DÉRIVÉS DE LA RAPAFUCINE ET PROCÉDÉS D'UTILISATION DE CEUX-CI
申请人:UNIV JOHNS HOPKINS
公开号:WO2021067439A1
公开(公告)日:2021-04-08
The present disclosure provides macrocyclic compounds inspired by the immunophilin ligand family of natural products FK506 and rapamycin. The generation of a Rapafucin library of macrocyles that contain FK506 and rapamycin binding domains should have great potential as new leads for developing drugs to be used for treating diseases.
Rational Alteration of Pharmacokinetics of Chiral Fluorinated and Deuterated Derivatives of Emixustat for Retinal Therapy
作者:Eliav Blum、Jianye Zhang、Jordan Zaluski、David E. Einstein、Edward E. Korshin、Adam Kubas、Arie Gruzman、Gregory P. Tochtrop、Philip D. Kiser、Krzysztof Palczewski